We are live on ! Find out more
TCA

Transcend Capital Advisors Portfolio holdings

AUM $1.25B
1-Year Est. Return 17.69%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+17.69%
3 Year Est. Return
+61.21%
5 Year Est. Return
+70.44%
10 Year Est. Return
AUM
$1.38B
AUM Growth
+$132M
Cap. Flow
+$110M
Cap. Flow %
7.96%
Top 10 Hldgs %
26.02%
Holding
618
New
82
Increased
295
Reduced
154
Closed
21

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 16.04%
3 Healthcare 10.13%
4 Consumer Discretionary 4.67%
5 Communication Services 3.74%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AGNC icon
51
AGNC Investment
AGNC
$12.4B
$5.65M 0.41%
592,674
+29,932
+5% +$286K
VPL icon
52
Vanguard FTSE Pacific ETF
VPL
$8.06B
$5.63M 0.41%
75,896
-1,297
-2% -$95.9K
ETN icon
53
Eaton
ETN
$155B
$5.38M 0.39%
17,150
+902
+6% +$291K
BGB
54
Blackstone Strategic Credit 2027 Term Fund
BGB
$500M
$5.35M 0.39%
449,567
+62,098
+16% +$738K
XLC icon
55
State Street Communication Services Select Sector SPDR ETF
XLC
$22.1B
$5.32M 0.39%
62,145
-3,553
-5% -$293K
VOO icon
56
Vanguard S&P 500 ETF
VOO
$968B
$5.31M 0.39%
10,622
-789
-7% -$380K
ORCL icon
57
Oracle
ORCL
$345B
$5.24M 0.38%
37,079
+1,116
+3% +$139K
PG icon
58
Procter & Gamble
PG
$346B
$5.24M 0.38%
31,744
-1,404
-4% -$230K
GLD icon
59
SPDR Gold Trust
GLD
$132B
$5.21M 0.38%
24,247
-328
-1% -$70.9K
UNH icon
60
UnitedHealth
UNH
$379B
$5.2M 0.38%
10,212
+948
+10% +$465K
PEP icon
61
PepsiCo
PEP
$191B
$5.12M 0.37%
31,049
+1,454
+5% +$251K
TEL icon
62
TE Connectivity
TEL
$60.2B
$5.04M 0.37%
33,530
+24,613
+276% +$3.61M
XBI icon
63
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$5.02M 0.36%
54,109
+3,774
+7% +$338K
AMLP icon
64
Alerian MLP ETF
AMLP
$12.7B
$4.77M 0.35%
99,364
+17,880
+22% +$835K
XLE icon
65
State Street Energy Select Sector SPDR ETF
XLE
$38.8B
$4.74M 0.34%
103,960
+454
+0.4% +$21.1K
SDY icon
66
State Street SPDR S&P Dividend ETF
SDY
$22B
$4.71M 0.34%
37,068
-240
-0.6% -$30.9K
WINN icon
67
Harbor Long-Term Growers ETF
WINN
$1.1B
$4.62M 0.34%
182,674
-2,308
-1% -$54.7K
XLF icon
68
State Street Financial Select Sector SPDR ETF
XLF
$56.7B
$4.57M 0.33%
111,243
+11,910
+12% +$490K
DOCU
69
DocuSign
DOCU
$10.1B
$4.36M 0.32%
81,517
TMO icon
70
Thermo Fisher Scientific
TMO
$208B
$4.33M 0.31%
7,831
+268
+4% +$154K
PFE icon
71
Pfizer
PFE
$141B
$4.33M 0.31%
154,768
+1,245
+0.8% +$34.3K
EMXC icon
72
iShares MSCI Emerging Markets ex China ETF
EMXC
$23.4B
$4.31M 0.31%
72,803
+1,024
+1% +$59K
BRK.A icon
73
Berkshire Hathaway Class A
BRK.A
$1.07T
$4.29M 0.31%
7
IVW icon
74
iShares S&P 500 Growth ETF
IVW
$72.2B
$4.27M 0.31%
46,098
+20,877
+83% +$1.8M
IEI icon
75
iShares 3-7 Year Treasury Bond ETF
IEI
$18.1B
$4.24M 0.31%
36,712
+739
+2% +$84.7K

Similar funds

Transcend Capital Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Transcend Capital Advisors held 618 positions worth $1.38B, up 11% from $1.25B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Transcend Capital Advisors deployed $110M of net new capital in Q2 2024, opening 82 new positions and adding to 295 existing holdings. Its largest new stake was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Blue Owl Capital, an estimated $10.9M trimmed.

  • Transcend Capital Advisors's largest Q2 2024 buy was Blue Owl Capital Corporation III: 577,763 shares worth $8.65M.
  • Transcend Capital Advisors added most to AstraZeneca in Q2 2024, an estimated $4.24M increase.
  • Transcend Capital Advisors's biggest Q2 2024 reduction was Blue Owl Capital, cutting an estimated $10.9M.
  • Transcend Capital Advisors fully exited Crane Co in Q2 2024, selling an estimated $480K.
  • Transcend Capital Advisors's ten largest holdings make up 26% of its $1.38B portfolio in Q2 2024.
  • Transcend Capital Advisors opened 82 new positions and closed 21 in Q2 2024.
  • Transcend Capital Advisors's portfolio value rose 11% quarter-over-quarter to $1.38B.

Based on Transcend Capital Advisors's 13F filing for Q2 2024, filed 2 Jul 2024.